Abstract:After emerging from the thymus, naive CD4 T cells circulate through secondary lymphoid tissues, including gut-associated lymphoid tissue of the intestine. The activation of naïve CD4 T cells by antigen-presenting cells offering cognate antigen initiate differentiation programs that lead to the development of highly specialized T helper (Th) cell lineages. Although initially believed that developmental programing of effector T cells such as T helper 1 (Th1) or T helper 2 (Th2) resulted in irreversible commitment to a fixed fate, subsequent studies have demonstrated greater flexibility, or plasticity, in effector T cell stability than originally conceived. This is particularly so for the Th17 subset, differentiation of which is a highly dynamic process with overlapping developmental axes with inducible regulatory T (iTreg), T helper 22 (Th22), and Th1 cells. Accordingly, intermediary stages of Th17 cells are found in various tissues, which co-express lineage-specific transcription factor(s) or cytokine(s) of developmentally related CD4 T cell subsets. A highly specialized tissue like that of the intestine, which harbors the largest immune compartment of the body, adds several layers of complexity to the intricate process of Th differentiation. Due to constant exposure to millions of commensal microbes and periodic exposure to pathogens, the intestinal mucosa maintains a delicate balance between regulatory and effector T cells. It is becoming increasingly clear that equilibrium between tolerogenic and inflammatory axes is maintained in the intestine by shuttling the flexible genetic programming of a developing CD4 T cell along the developmental axis of iTreg, Th17, Th22, and Th1 subsets. Currently, Th17 plasticity remains an unresolved concern in the field of clinical research as targeting Th17 cells to cure immune-mediated disease might also target its related subsets. In this review, we discuss the expanding sphere of Th17 plasticity through its shared developmental axes with related cellular subsets such as Th22, Th1, and iTreg in the context of intestinal inflammation and also examine the molecular and epigenetic features of Th17 cells that mediate these overlapping developmental programs.

Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity

Microbiota-specific Th17 Cells: Yin and Yang in Regulation of Inflammatory Bowel Disease.

Cellular and Molecular Dynamics of Th17 Differentiation and its Developmental Plasticity in the Intestinal Immune Response

Potential Role of Th17 Cells in the Pathogenesis of Inflammatory Bowel Disease.

The Inflammatory Th 17 Subset in Immunity Against Self and Non-Self Antigens

Homeostatic intestinal immunity is dominated by microbiota-independent cytotoxic Th1 cells

IL-17 controls central nervous system autoimmunity through the intestinal microbiome

Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology

Th17 Cells: a New Fate for Differentiating Helper T Cells

Phenotypic and functional features of human Th17 cells

The pathogenicity of Th17 cells in autoimmune diseases

T helper 17 (Th17) cell responses to the gut microbiota in human diseases

Induction of a colitogenic phenotype in Th1-like cells depends on interleukin-23 receptor signaling

Characterization of Th17 tissue-resident memory cells in non-inflamed intestinal tissue of Crohn's disease patients

Contribution of gut-derived T cells to extraintestinal autoimmune diseases

Selective IL-27 production by intestinal regulatory T cells permits gut-specific regulation of T H 17 cell immunity

Gut pathobiont translocation induces lymphocyte migration to internal organs in autoimmunity

The Treg/Th17 Axis: A Dynamic Balance Regulated by the Gut Microbiome

A Th17 cell-intrinsic glutathione/mitochondrial-IL-22 axis protects against intestinal inflammation

TH17 cell: a double-edged sword in the development of inflammatory bowel disease

The Balance of Th17 versus Treg Cells in Autoimmunity